NHS
BIVDA Report Outlines UK Access Barriers to Genetic, Genomic Diagnostics
Challenges identified in the white paper include a lack of centralized guidance to apply for funding for genomic technologies and a shortage of infrastructure to educate physicians and patients.
UK National Health Service Rolls out Lynch Syndrome Genetic Testing
The new service will not only help guide patient treatment but also identify relatives who might be at higher risk of developing certain cancers.
Cost of implementation, interoperability challenges, and lagging reimbursement can often outweigh the benefits of transitioning a lab to digital pathology.
Ibex announced earlier this month that it had secured several contracts to offer Galen Prostate and Galen Breast to 25 UK National Health Service trusts.
UK NHS Expands Access to Ibex Cancer Diagnostics
The Tel Aviv, Israel-based company has received multiple contracts for its products through PathLAKE, a center of excellence consortium backed by Innovate UK.